Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 24, Issue 2, 2006, Pages 174-178

  Namboodiri, Aryan M ^a   Rocca, Keith M ^a   Kuwana, Masataka ^b   Pandey, Janardan P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diffuse; Humoral immunity; Limited; Scleroderma

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; HUMAN CYTOMEGALOVIRUS PROTEIN UL83; IMMUNOGLOBULIN G ANTIBODY; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYTOMEGALOVIRUS MATRIX PROTEIN 65KDA; DNA DIRECTED RNA POLYMERASE; DNA TOPOISOMERASE; IMMUNOGLOBULIN G; MATRIX PROTEIN; PHOSPHOPROTEIN;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SCLERODERMA; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; BLOOD; CENTROMERE; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PATHOGENICITY; VIROLOGY;

AUTOANTIBODIES; CENTROMERE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA TOPOISOMERASES, TYPE I; DNA-DIRECTED RNA POLYMERASES; HUMANS; IMMUNOGLOBULIN G; PHOSPHOPROTEINS; SCLERODERMA, SYSTEMIC; VIRAL MATRIX PROTEINS;

EID: 33744799410     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. MEDSGER Jr. TA, DERK CT, JIMENEZ SA: Systemic sclerosis (scleroderma): clinical aspects. In KOOPMAN WJ (Ed.): Arthritis and Allied Conditions: A Textbook of Rheumatology. 14th ed. Philadelphia, Lippincott Williams and Wilkins 2001: 1590-624.
2. HAMAMDZIC D, KASMAN LM, LEROY EC: The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002; 14: 694-8.
3. PANDEY JP, LEROY EC: Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis Rheum 1998; 41: 10-15.
4. NEIDHART M, KUCHEN S, DISTLER O et al.: Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis Rheum 1999; 42: 389-92.
5. LUNARDI C, BASON C, NAVONE R et al.: Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6: 1183-6.
6. NAMBOODIRI AM, ROCCA KM, PANDEY JP: IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Autoimmunity 2004; 37: 241-4.
7. MURYOI T, KASTURI KN, KAFINA MJ et al.: Anti-topoisomerase monoclonal antibodies from scleroderma patients and tight skin mouse interact with similar epitopes. J Exp Med 1992; 175: 1103-9.
8. FERRI C, CAZZATO M, GIUGGIOLI D, SEBASTIANI M, MAGRO C: Systemic sclerosis following human cytomegalovirus infection. Ann Rheum Dis 2002; 61: 937-8.
9. LUNARDI C, BASON C, CORROCHER R, PUCCETTI A: Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol 2005; 26: 19-24.
10. OHLIN M, PLACHTER B, SUNDQVIST VA, STEENBAKKERS PG, MIDDELDORP JM, BORREBAECK CA: Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus. Clin Diagn Lab Immunol 1995; 2: 325-9.
11. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
12. KUWANA M, KABURAKI J, OKANO Y, TOJO T, HOMMA M: Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994; 37: 75-83.
13. KUWANA M, PANDEY JP, SILVER RM, KAWAKAMI Y, KABURAKI J: HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: Associations with subunit reactivities. J Rheumatol 2003; 30: 2392-7.
14. HU PQ, FERTIG N, MEDSGER TA JR, WRIGHT TM: Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 2003; 48: 1363-73.
15. KUWANA M, OKANO Y, PANDEY JP, SILVER RM, FERTIG N, MEDSGER TA: Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: Analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum 2005; 52: 2425-32.
16. FERRI C, ZAKRZEWSKA K, LONGOMBARDO G et al.: Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999; 17: 718-20.
17. BRITT WJ, ALFORD CA: Cytomegalovirus. In FIELDS BN, KNIFE DM, HOWLEY PM (Eds.): Fields Virology, Vol. 2. Raven Press, New York, 1996: 2493-523.
18. PANDEY JP: Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Clin Exp Rheumatol 2004; 22: S35-7.